John Peter Gutfreund is of Oncocyte Corp. Currently has a direct ownership of 715,000 shares of OCX, which is worth approximately $1.57 Million. The most recent transaction as insider was on Apr 03, 2023, when has been sold 705,000 shares (Common Stock, No Par Value) at a price of $0.35 per share, resulting in proceeds of $246,749. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 715K
0% 3M change
0% 12M change
Total Value Held $1.57 Million

John Peter Gutfreund Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2023
BUY
Grant, award, or other acquisition
$246,749 $0.35 p/Share
705,000 Added 49.65%
715,000 Common Stock, No Par V...
Aug 15 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 50.0%
10,000 Common Stock, No Par V...
JPG

John Peter Gutfreund

Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Track Activities on OCX